Skip to main content

Refine your results

Filters
Date
Displaying 1 - 20 of 112

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book

Date
By
Lina M. Khan, Chair
Related Releases
FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc

Date
By
Lina M. Khan, Chair;
Alvaro Bedoya, Commissioner;
Rebecca Kelly Slaughter, Commissioner
Related Releases
Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition

Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation

In the Matter of EQT Corporation
Date
Matter Number

2210212

By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner;
Alvaro Bedoya, Commissioner
Related Releases
FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal

Testimony of the Federal Trade Commission Before the House Committee on the Judiciary Concerning Oversight of the FTC

Before the House Committee on the Judiciary
Washington, D.C.
Congressional Session
117th Congress
Date
Matter Number

P210100

By
Lina M. Khan, Chair
Related Releases
FTC Provides Testimony Before the House Judiciary Committee at Oversight Hearing

Statement of Chair Lina M. Khan Joined by Commissioners Slaughter and Bedoya Regarding Proposed Amendments to the Premerger Notification Form and the Hart-Scott-Rodino Rules

Date
By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner;
Alvaro Bedoya, Commissioner
Related Releases
FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Publishers Clearing House

Date
Matter Number

182 3145

By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner;
Alvaro Bedoya, Commissioner
Related Releases
FTC Takes Action Against Publishers Clearing House for Misleading Consumers About Sweepstakes Entries

Policy Statement of the Federal Trade Commission on Biometric Information and Section 5 of the Federal Trade Commission Act

Policy Statement on Biometric Information and Section 5 of the FTC Act
Date
Matter Number

P225402

By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner;
Alvaro Bedoya, Commissioner
Related Releases
FTC Warns About Misuses of Biometric Information and Harm to Consumers

Testimony of the Federal Trade Commission Before the House Committee on Appropriations Concerning the Agency's FY2024 Budget Request

Before the House Committee on Appropriations Subcommittee on Financial Services and General Government
Washington, D.C.
Congressional Session
117th Congress
Date
Matter Number

P210100

By
Lina M. Khan, Chair
Related Releases
FTC Testifies Before House Appropriations Subcommittee
Displaying 1 - 20 of 112

Join us at the FTC!

View our open positions

Return to top